<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2520-9825</journal-id>
<journal-title><![CDATA[Revista Científica de Salud UNITEPC]]></journal-title>
<abbrev-journal-title><![CDATA[Revista UNITEPC]]></abbrev-journal-title>
<issn>2520-9825</issn>
<publisher>
<publisher-name><![CDATA[Universidad Tecnica Privada Cosmos]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2520-98252023000100020</article-id>
<article-id pub-id-type="doi">10.36716/unitepc.v10i1.392</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Evaluación de prueba inmunocromatográfica para la detección de anticuerpos IgM e IgG contra SARS-CoV-2]]></article-title>
<article-title xml:lang="en"><![CDATA[Evaluation of immunochromatographic test for the detection of IgM and IgG antibodies against SARS-CoV-2]]></article-title>
<article-title xml:lang="pt"><![CDATA[Avaliação de teste imunocromatográfico para detecção de anticorpos IgM e IgG contra SARS-CoV-2]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Villca Chuquichambi]]></surname>
<given-names><![CDATA[Moria]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Orellana Guevara]]></surname>
<given-names><![CDATA[Raquel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Condori Mamani]]></surname>
<given-names><![CDATA[Abigail]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Choque-Medrano]]></surname>
<given-names><![CDATA[Juan Wilfredo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Adventista de Bolivia  ]]></institution>
<addr-line><![CDATA[Cochabamba ]]></addr-line>
<country>Bolivia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Adventista de Bolivia  ]]></institution>
<addr-line><![CDATA[Cochabamba ]]></addr-line>
<country>Bolivia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Adventista de Bolivia  ]]></institution>
<addr-line><![CDATA[Cochabamba ]]></addr-line>
<country>Bolivia</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad Adventista de Bolivia  ]]></institution>
<addr-line><![CDATA[Cochabamba ]]></addr-line>
<country>Bolivia</country>
</aff>
<pub-date pub-type="pub">
<day>30</day>
<month>06</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>06</month>
<year>2023</year>
</pub-date>
<volume>10</volume>
<numero>1</numero>
<fpage>20</fpage>
<lpage>26</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_arttext&amp;pid=S2520-98252023000100020&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_abstract&amp;pid=S2520-98252023000100020&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_pdf&amp;pid=S2520-98252023000100020&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción:  Las pruebas inmunológicas son utilizadas como diagnóstico complementario en la vigilancia epidemiológica. Objetivos: Evaluar la prueba inmunocromatográfica para la detección de anticuerpos IgM e IgG contra el SARS-CoV-2, usando como prueba de referencia ELISA IgM/IgG para COVID-19. Metodología: El estudio realizado comparó pruebas inmunocromatográficas IgM/IgG con la prueba de ELISA IgM/IgG. También se efectuó la estimación de sensibilidad y especificidad de dicha prueba. Se trabajó con 50 muestras de suero para IgM y 50 muestra para IgG. Resultados: La sensibilidad de la prueba Inmunocromatográfica evaluada para la detección de anticuerpos IgM fue de 78,95 % y una especificidad de 48,39 %. En cuanto a la prueba inmunocromatográfica para la detección de anticuerpos, IgG fue de 72,00 % de sensibilidad y especificidad de 76,00 %. Discusión: La concordancia entre la prueba inmunocromatográfica para la detección de anticuerpos IgM/IgG y la prueba de ELISA para la detección de anticuerpos IgM/IgG muestra una concordancia regular y Moderada según el Índice kappa. La evaluación de pruebas inmunocromatográficas presenta una sensibilidad y especificidad menor frente a otras pruebas.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Introduction: Immunological tests are used as a complementary diagnosis in epidemiological surveillance. Objectives: To evaluate the immunochromatographic test for the detection of IgM and IgG antibodies against SARS-CoV-2, using ELISA IgM/IgG as a reference test for COVID-19. Methodology: The study carried out compared IgM/IgG immunochromatographic tests with the ELISA IgM/IgG test. The estimation of sensitivity and specificity of said test was also carried out. We worked with 50 serum samples for IgM and 50 samples for IgG. Results: The sensitivity of the immunochromatographic test evaluated for the detection of IgM antibodies was 78.95% and a specificity of 48.39%. Regarding the immunochromatographic test for the detection of antibodies, IgG was 72.00% sensitive and 76.00% specific. Discussion: The agreement between the immunochromatographic test for the detection of IgM/IgG antibodies and the ELISA test for the detection of IgM/IgG antibodies shows a regular and moderate agreement according to the kappa index. The evaluation of immunochromatographic tests presents a lower sensitivity and specificity compared to other tests.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Introdução:  Os testes imunológicos são utilizados como diagnóstico complementar na vigilância epidemiológica. Objetivos: Avaliar o teste imunocromatográfico para detecção de anticorpos IgM e IgG contra SARS-CoV-2, utilizando o ELISA IgM/IgG como teste de referência para COVID-19. Metodologia: O estudo realizado comparou testes imunocromatográficos IgM/IgG com o teste ELISA IgM/IgG. A estimativa da sensibilidade e especificidade do referido teste também foi realizada. Trabalhamos com 50 amostras de soro para IgM e 50 amostras para IgG. Resultados: A sensibilidade do teste imunocromatográfico avaliado para detecção de anticorpos IgM foi de 78,95% e especificidade de 48,39%. Em relação ao teste imunocromatográfico para detecção de anticorpos, a IgG foi 72,00% sensível e 76,00% específica. Discussão: A concordância entre o teste imunocromatográfico para detecção de anticorpos IgM/IgG e o teste ELISA para detecção de anticorpos IgM/IgG apresenta concordância Regular e Moderada segundo o Índice kappa. A avaliação dos testes imunocromatográficos apresenta menor sensibilidade e especificidade em relação a outros testes.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Anticuerpos]]></kwd>
<kwd lng="es"><![CDATA[COVID-19]]></kwd>
<kwd lng="es"><![CDATA[Pruebas Inmunológicas]]></kwd>
<kwd lng="en"><![CDATA[Antibodies]]></kwd>
<kwd lng="en"><![CDATA[COVID-19]]></kwd>
<kwd lng="en"><![CDATA[Immunologic Tests]]></kwd>
<kwd lng="pt"><![CDATA[Anticorpos]]></kwd>
<kwd lng="pt"><![CDATA[COVID-19]]></kwd>
<kwd lng="pt"><![CDATA[Testes Imunológicos]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosón]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Pisula]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Báez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Loza]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Taito]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Cisneros]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Franco]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Métodos diagnósticos para la infección por SARS-CoV-2]]></article-title>
<source><![CDATA[Revista del Hospital Italiano de Buenos Aires]]></source>
<year>2020</year>
<volume>40</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1-9</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aguilar-Gamboa]]></surname>
<given-names><![CDATA[FR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Desafíos para el manejo y detección de pacientes con COVID-19 en Latinoamérica]]></article-title>
<source><![CDATA[Rev Exp En Med Hosp Reg Lambayeque]]></source>
<year>2020</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>43-50</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vidal-Anzardo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Solis]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Solari]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Minaya]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Ayala-Quintanilla]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Astete-Cornejo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluación en condiciones de campo de una prueba serológica rápida para detección de anticuerpos IgM e IgG contra SARS-CoV-2]]></article-title>
<source><![CDATA[Rev Perú Med Exp Salud Pública]]></source>
<year>2020</year>
<volume>37</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>203-9</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pinilla]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Navarrete O]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnóstico molecular de SARS-CoV-2]]></article-title>
<source><![CDATA[Nova]]></source>
<year>2020</year>
<volume>18</volume>
<numero>35</numero>
<issue>35</issue>
<page-range>35-41</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz Jiménez]]></surname>
<given-names><![CDATA[IV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Interpretación de las pruebas diagnósticas del virus SARS- Cov-2]]></article-title>
<source><![CDATA[Acta Pediatr Mex]]></source>
<year>2020</year>
<volume>41</volume>
<numero>Supl1</numero>
<issue>Supl1</issue>
<page-range>51-7</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vizcaíno-Carruyo]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Tangarife-Castaño]]></surname>
<given-names><![CDATA[VJ]]></given-names>
</name>
<name>
<surname><![CDATA[Campuzano-Zuluaga]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Toro-Montoya]]></surname>
<given-names><![CDATA[AI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19 anticuerpos IgM/IgG por ensayo inmunocromatográfico (prueba rápida).]]></article-title>
<source><![CDATA[Medicina &amp; Laboratorio]]></source>
<year>2020</year>
<volume>24</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>255-7</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Langa]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
<name>
<surname><![CDATA[Sallent]]></surname>
<given-names><![CDATA[LV]]></given-names>
</name>
<name>
<surname><![CDATA[Díez]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Interpretación de las pruebas diagnósticas de la COVID-19]]></article-title>
<source><![CDATA[FMC]]></source>
<year>2021</year>
<volume>28</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>167-73</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valencia Portillo]]></surname>
<given-names><![CDATA[RT]]></given-names>
</name>
<name>
<surname><![CDATA[Amorín Uscata]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Gonzales-Zubiate]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
<name>
<surname><![CDATA[Juscamaita Medina]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Sevillano]]></surname>
<given-names><![CDATA[OR]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos-Sánchez]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pruebas rápidas para COVID-19, la mejor alternativa para Ecuador]]></article-title>
<source><![CDATA[Bionatura]]></source>
<year>2020</year>
<volume>5</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1280-3</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="">
<source><![CDATA[Epitope Diagnostics Inc. Novel Coronavirus COVID-19 IgM ELISA Kit KT-1033+IVD,CE+V7. 2020]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="">
<source><![CDATA[Eagle Biosciences]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="">
<source><![CDATA[Test_COVID_19_AccuTell_ES.pdf]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vizcaíno-Salazar]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Importancia del cálculo de la sensibilidad, la especificidad y otros parámetros estadísticos en el uso de las pruebas de diagnóstico clínico y de laboratorio]]></article-title>
<source><![CDATA[Medicina y Laboratorio]]></source>
<year>2017</year>
<volume>23</volume>
<numero>7-8</numero>
<issue>7-8</issue>
<page-range>365-86</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Manterola]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Grande]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Otzen]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Salazar]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Quiroz]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Confiabilidad, precisión o reproducibilidad de las mediciones Métodos de valoración, utilidad y aplicaciones en la práctica clínica]]></article-title>
<source><![CDATA[Rev. chilena Infectol]]></source>
<year>2018</year>
<volume>35</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>680-8</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Almonacid Urrego]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Girata Pedraza]]></surname>
<given-names><![CDATA[MV]]></given-names>
</name>
<name>
<surname><![CDATA[Salcedo Pretelt]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Amonacid Urrego]]></surname>
<given-names><![CDATA[IC.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Papel de las pruebas rápidas (POCT) en el diagnóstico del SARS-COV-2, agente causal de COVID-19]]></article-title>
<source><![CDATA[Rev. Nova]]></source>
<year>2020</year>
<volume>18</volume>
<numero>35</numero>
<issue>35</issue>
<page-range>43-52</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[González-Fiallo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mena-Rodríguez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Doeste-Hernández]]></surname>
<given-names><![CDATA[VM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validación de pruebas rápidas de COVID-19 Isla de la Juventud, Cuba]]></article-title>
<source><![CDATA[VacciMonitor]]></source>
<year>2021</year>
<volume>30</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>105-14</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pegoraro]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Militello]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Salvagno]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
<name>
<surname><![CDATA[Gaino]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bassi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Caloi]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Peretti]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bizzego]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Poletto]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bovo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lippi]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Lo Cascio]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of three immunochromatographic tests in COVID-19 serologic diagnosis and their clinical usefulness]]></article-title>
<source><![CDATA[Eur J Clin Microbiol Infect Dis]]></source>
<year>2021</year>
<volume>40</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>897-900</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Yi]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Luo]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Xiong]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis]]></article-title>
<source><![CDATA[J Med Virol]]></source>
<year>2020</year>
<volume>92</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1518-24</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
